{
    "resourceType": "Bundle",
    "type": "collection",
    "entry": [
      {
        "fullUrl": "http://example.org/fhir/EvidenceReport/MA4568",
        "resource": {
          "resourceType": "EvidenceReport",
          "status": "draft",
          "identifier": [{
            "value": "4568",
            "system": "https://app.magicapp.org/#/guidelines"
          }],
          "subject": {
            "characteristic": [
              {
                "code": "Population",
                "valueReference": {
                  "reference": "Population_COVID-19_Oxygen-Saturation<90"
                }
              },
              {
                "code": "Intervention",
                "valueReference": {
                  "reference": "6mg_10d_Dexamethasone_once/d"
                }
              },
              {
                "code": "Recommendation",
                "valueReference": {
                  "reference": "Recommendation_https://app.magicapp.org/#/guidelines_4568_1"
                }
              }
            ]
          },
          "section": [
            {
              "title": "Population Section",
              "focus": "EvidenceVariable-population",
              "text": "COVID-19_Oxygen-Saturation<90",
              "entryReference": [
                {
                  "type": "Group",
                  "identifier": {
                    "value": "Population_COVID-19_Oxygen-Saturation<90",
                    "system": "https://covid-evidenz.de/"
                  }
                }
              ]
            },
            {
              "title": "Intervention Section",
              "focus": "EvidenceVariable-intended",
              "text": "6mg_10d_Dexamethason_once/d",
              "entryReference": [
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Intervention_6mg_10d_Dexamethasone_once/d",
                    "system": "https://covid-evidenz.de/"
                  }
                }
              ]
            },
            {
              "title": "Recommendation Section",
              "focus": "Recommendation",
              "text": "https://app.magicapp.org/#/guidelines / 4568",
              "entryReference": [
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Recommendation_https://app.magicapp.org/#/guidelines_4568_1",
                    "system": "https://covid-evidenz.de/"
                  }
                }
              ]
            }
          ]
        }
      },
      {
        "resource": {
          "resourceType": "Group",
          "identifier": [
            {
            "value" : "Population_COVID-19_Oxygen-Saturation<90",
            "system": "https://covid-evidenz.de/"
            }
          ],
          "type": "person",
          "actual": false,
          "name": "Population for guideline from https://app.magicapp.org/#/guidelines / 4568 with characteristics: COVID-19, Oxygen-Saturation<90",
          "characteristic": [
            {
              "code": {
                "text": "Condition",
                "coding": [
                  {
                    "system": "http://data.cochrane.org/ontologies/pico/",
                    "code": "Condition",
                    "display": "Cochrane Pico Ontology: Condition"
                  }
                ]
              },
              "valueCodeableConcept": {
                "text": "Covid-19",
                "coding": [
                  {
                    "system": "https://data.cochrane.org/concepts/",
                    "code": "NrO30O5ZnYIkjE",
                    "display": "Cochrane Linked Data Vocabulary: Condition - COVID-19"
                  },
                  {
                    "system": "http://snomed.info/sct",
                    "code": "840539006",
                    "display": "SnomedCT: Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)"
                  }

                ]
              },
              "exclude": false
            },
            {
              "code": {
                "text": "Condition",
                "coding": [
                  {
                    "system": "http://data.cochrane.org/ontologies/pico/",
                    "code": "Condition",
                    "display": "Cochrane Pico Ontolgy - Condition"
                  }
                ]
              },
              "valueCodeableConcept": {
                "text": "Oxygen-Saturation<90",
                "coding": [
                  {
                    "system": "https://data.cochrane.org/concepts/",
                    "code": "r4hp3qjmm9l6",
                    "display": "Cochrane Linked Data Vocabulary: Condition - Oxygen Saturation"
                  },
                  {
                    "system": "http://snomed.info/sct",
                    "code": "431314004",
                    "display": "SnomedCT: Peripheral oxygen saturation (observable entity)"
                  },
                  {
                    "system": "https://covid-evidenz.de/max",
                    "code": "90",
                    "display": "max-value = 90"
                  }
                ]
              },
              "exclude": false
            }
          ]
        }
      },
     
      {
        "resource": {
          "resourceType": "EvidenceVariable",
          "identifier": [
            {
              "value" : "6mg_10d_Dexamethasone_once/d",
              "system": "https://covid-evidenz.de/"
              }
            ],
          "status": "draft",
          "name": "Intervetion for guideline from https://app.magicapp.org/#/guidelines / 4568 with characteristics: Dexamethason, 6mg, 10d, once/d",
          "characteristic": [
            {
              "definitionCodeableConcept": {
                "text": "6mg",
                "coding": [
                  {
                    "system": "https://covid-evidenz.de/",
                    "code": "6mg",
                    "display": "6 miligram"
                  },
                  {
                    "system": "http://snomed.info/sct",
                    "code": "398232005",
                    "display": "SnomedCT: Drug dose (finding) "
                  },
                  {
                    "system": "https://covid-evidenz.de/unit",
                    "code": "mg"
                  },
                  {
                    "system": "https://covid-evidenz.de/value",
                    "code": "6"
                  } 
                ]
              },
              "method": {
                "text": "Dose",
                "coding": [
                  {
                    "system": "http://data.cochrane.org/ontologies/pico/",
                    "code": "Dose",
                    "display": "Cochrane Pico Ontolgy - Dose"
                  }
                ]
              },
              "exclude": false
            },
            {
              "definitionCodeableConcept": {
                "text": "10d",
                "coding": [
                  {
                    "system": "https://covid-evidenz.de/",
                    "code": "10d",
                    "display": "10 days"
                  },
                  {
                    "system": "http://snomed.info/sct",
                    "code": "261774000",
                    "display": "SnomedCT: Duration of treatment (qualifier value) "
                  },
                  {
                    "system": "https://covid-evidenz.de/unit",
                    "code": "days"
                  },
                  {
                    "system": "https://covid-evidenz.de/value",
                    "code": "10"
                  }            
                ]
              },
              "method": {
                "text": "Duration",
                "coding": [
                  {
                    "system": "http://data.cochrane.org/ontologies/pico/",
                    "code": "Duration",
                    "display": "Cochrane Pico Ontolgy - Duration"
                  }
                ]
              },
              "exclude": false
            },
            {
              "definitionCodeableConcept": {
                "text": "Dexamethasone",
                "coding": [
                  {
                    "system": "https://data.cochrane.org/concepts/",
                    "code": "r4hp13q3f0kh",
                    "display": "Cochrane Linked Data Vocabulary: Drug - Dexamethasone"
                  },
                  {
                    "system": "http://snomed.info/sct",
                    "code": "372584003",
                    "display": "SnomedCT: Dexamethasone (substance)"
                  }
                ]
              },
              "method": {
                "text": "Intervention",
                "coding": [
                  {
                    "system": "http://data.cochrane.org/ontologies/pico/",
                    "code": "Intervention",
                    "display": "Cochrane Pico Ontolgy - Intervention"
                  }
                ]
              },
              "exclude": false
            },
            {
              "definitionCodeableConcept": {
                "text": "once/d",
                "coding": [
                  {
                    "system": "http://snomed.info/sct",
                    "code": "229797004",
                    "display": "SnomedCT: Once daily (qualifier value)"
                  }
                ]
              },
              "method": {
                "text": "Schedule",
                "coding": [
                  {
                    "system": "http://data.cochrane.org/ontologies/pico/",
                    "code": "Schedule",
                    "display": "Cochrane Pico Ontolgy - Schedule"
                  }
                ]
              },
              "exclude": false
            }
          ]
        }
      },
  
      {
        "resource": {
          "resourceType": "Evidence",
          "identifier": [
            {
              "value" : "Recommendation_https://app.magicapp.org/#/guidelines_4568_1",
              "system": "https://covid-evidenz.de/"
          }],
          "title": "https://app.magicapp.org/#/guidelines / 4568",
          "status": "draft",
          "description": "Bei Patienten mit schwerer (SpO2 < 90 %, Atemfrequenz > 30/min) oder kritischer (ARDS, Sepsis, Beatmung, Vasopressorengabe) COVID-19-Erkrankung soll eine Therapie mit Dexamethason erfolgen. Die Dosis beträgt 6 mg Dexamethason p. o./i. v. täglich für 10.",
          "variableDefinition": [
            {
              "variableRole": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/variable-role/",
                    "code": "population"
                  }
                ]
              },
              "observed": {
                "type": "Group",
                "identifier": {
                  "value": "Population_COVID-19_Oxygen-Saturation<90"
                },
                "display": "Population for guideline from https://app.magicapp.org/#/guidelines / 4568 with characteristics: COVID-19, Oxygen-Saturation<90"
              }
            },
            {
              "variableRole": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/variable-role/",
                    "code": "exposure"
                  }
                ]
              },
              "observed": {
                "type": "EvidenceVariable",
                "identifier": {
                  "value": "Intervention_6mg_10d_Dexamethasone_once/d"
                },
                "display": "Intervetion for guideline from https://app.magicapp.org/#/guidelines / 4568 with characteristics: Dexamethasone, 6mg, 10d, once/d"
              }
            }
          ],
          "statistic": [
            {
              "description": "net effect estimate",
              "statisticType": "reltive risk",
              "modelCharacteristic": [
                {
                  "code": "relative risk",
                  "value": "2"
                }
              ]
            }
          ],
          "certainty": [
            {
              "description": "Moderate certainty due to ...",
              "type": {
                "coding": [
                  {
                    "system": "http://hl7.org/fhir/ValueSet/certainty-type/",
                    "code": "Overall"
                  }
                ]
              },
              "rating": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/certainty-rating/",
                    "code": "low"
                  }
                ]
              }
            }
          ]
        }
      }
    ]
  }